Eden Research Share Discussion Threads

[quazie12] 23/10/2021 08:12

Another suggestion. Go back as far back as you want. You will read COUNTLESS rns issued by Eden highlighting some regulatory approval in a far off land in time for next years growing season then ask the company on the next Q&A what the lifetime sales are.

[quazie12] 23/10/2021 08:06

Eden has guzzled what ? 35 million quid tet turnover, not profits but turnover is still negligible. I mean ffs. What are the combined salaries if the BoD here ? What us the ratio of directors salary to turnover ? Work it out, I have.

[investingisatrickygame] 22/10/2021 18:04

I am not seeing his/her posts, but given what Spadeychops is saying, why didn't he/she call themself NegativePOV?

Much more accurate

[neutralpov] 22/10/2021 12:40

Nonstop lies and propaganda above.

Replace the x's with F-Offs.

[investingisatrickygame] 22/10/2021 09:56

hxxps://youtu.be/iQdlOahnzI0

Replace the x's with t's

[timbo_slice] 21/10/2021 16:22

I'm afraid my trading and investments elsewhere preclude me from playing the role of the gullible rube.

[investingisatrickygame] 21/10/2021 15:50

Chrischas

Annual Report RNS28/9/2021 refers to channel stocking (sales to you & me) upon US EPA approval and in time for the 2022 growing season.

No doubt all those vehemently criticising here are doing exceptionally well at work, over-performing, out-selling their colleagues and are superstars. It's like football fans, aggressive in their condemnation and criticism of players and managers, giving no consideration for their own work performance, but verbally, willing to rip others apart.

Pathetic!

[chrischas] 21/10/2021 15:04

" We are currently in the process of securing regulatory approval for Eden's flagship products - Mevalone(R) and Cedroz(TM) - in the U.S., which will present significant market opportunities for the business in that region."

He still cannot bring himself to use that Horrible word "SALES". As in :


We are currently in the process of securing regulatory approval for Eden's flagship products - Mevalone(R) and Cedroz(TM) - in the U.S., which will present significant SALES opportunities for the business in that region.

[neutralpov] 21/10/2021 14:53

chops, you donk, are the one admitting you hold """shares""" (lol) in the pension fund of/for people who mean nothing to you, in the hope that they change their habits and eventually throw you a crumb.

So you are in no position at all to lecture or hector anyone else.

Any part of that you can't understand, you cucking funt?

[neutralpov] 21/10/2021 14:03

lol

Idiot-counter here keeps incrementing.

[timbo_slice] 21/10/2021 10:06

You've logged in as the wrong profile.

[investingisatrickygame] 20/10/2021 22:04

Please note from today's RNS

"Eden is supporting this listing on OTCQB with new investor relations activity in the U.S. aimed at creating visibility for U.S. investors, broadening the Company's shareholder base and improving stock liquidity."

[timbo_slice] 20/10/2021 18:29

I'm sure... So back to holding for a takeover or zero...... anything not to have to trade with these market makers who can move the share price at their whim. Let's see what happens tomorrow...

[bjlk] 20/10/2021 17:05

Look at bluejay..... nothing will happen

[timbo_slice] 20/10/2021 16:23

Some might argue the extra liquidity from the OTC market is a good thing as it will help with price discovery.